From: Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects
Treatment a
RNA recovery (% control ± SD) b
RNA integrity (RIN) c
Medium
100.0
9.6
Au NPs 4 nm
96.3 ± 5.8
AgO NPs
78.8 ± 7.7
9.5
CoO NPs
97.2 ± 3.8
CeO 2 NPs
56.5 ± 4.9 *
9.8
Solvents (all)
97.3 ± 3.4